Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
269 studies found for:    Open Studies | "Esophageal Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Spray Cryotherapy for Esophageal Cancer (ICE-CANCER)
Condition: Esophageal Cancer
Intervention: Device: Liquid nitrogen spray cryotherapy with the truFreeze device
22 Unknown  Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery
Condition: Esophageal Cancer
Interventions: Biological: cetuximab;   Drug: cisplatin;   Drug: fluorouracil;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy
23 Recruiting PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy
Conditions: Adenocarcinoma of the Gastroesophageal Junction;   Esophageal Cancer
Interventions: Drug: FOLFOX regimen;   Drug: carboplatin;   Drug: fluorouracil;   Drug: leucovorin calcium;   Drug: oxaliplatin;   Drug: paclitaxel
24 Unknown  S-1, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIA, Stage III, or Stage IVA Esophageal Cancer That Can Be Removed by Surgery
Condition: Esophageal Cancer
Interventions: Drug: cisplatin;   Drug: tegafur-gimeracil-oteracil potassium;   Other: cytology specimen collection procedure;   Procedure: endoscopic biopsy
25 Recruiting Esophageal Cancer Tissue Banking
Condition: Esophageal Cancer
Intervention:
26 Recruiting Pronase Improves Efficacy of Chromoendoscopy Screening on Esophageal Cancer
Condition: Esophageal Neoplasms
Interventions: Drug: Pronase;   Drug: Control No pronase plus Dimethicone and sodium bicarbonate
27 Recruiting Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by Surgery
Conditions: Adenocarcinoma of the Esophagus;   Adenocarcinoma of the Gastroesophageal Junction;   Diffuse Adenocarcinoma of the Stomach;   Intestinal Adenocarcinoma of the Stomach;   Mixed Adenocarcinoma of the Stomach;   Recurrent Esophageal Cancer;   Recurrent Gastric Cancer;   Squamous Cell Carcinoma of the Esophagus;   Stage IIIB Esophageal Cancer;   Stage IIIB Gastric Cancer;   Stage IIIC Esophageal Cancer;   Stage IIIC Gastric Cancer;   Stage IV Esophageal Cancer;   Stage IV Gastric Cancer
Interventions: Drug: cyclodextrin-based polymer-camptothecin CRLX101;   Other: Laboratory biomarker analysis;   Other: Pharmacological studies
28 Recruiting Endoscopic Prevention of Esophageal Cancer at Tenwek Hospital
Conditions: Esophageal Cancer;   Esophageal Squamous Dysplasia
Interventions: Procedure: Endoscopic Mucosal Resection (EMR);   Device: Radiofrequency ablation
29 Recruiting Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer
Conditions: Adenocarcinoma of the Esophagus;   Adenocarcinoma of the Gastroesophageal Junction;   Diffuse Adenocarcinoma of the Stomach;   Intestinal Adenocarcinoma of the Stomach;   Mixed Adenocarcinoma of the Stomach;   Squamous Cell Carcinoma of the Esophagus;   Stage IA Esophageal Cancer;   Stage IA Gastric Cancer;   Stage IB Esophageal Cancer;   Stage IB Gastric Cancer;   Stage IIA Esophageal Cancer;   Stage IIA Gastric Cancer;   Stage IIB Esophageal Cancer;   Stage IIB Gastric Cancer;   Stage IIIA Esophageal Cancer;   Stage IIIA Gastric Cancer;   Stage IIIB Esophageal Cancer;   Stage IIIB Gastric Cancer;   Stage IIIC Esophageal Cancer;   Stage IIIC Gastric Cancer
Interventions: Biological: bevacizumab;   Drug: oxaliplatin;   Drug: leucovorin calcium;   Drug: fluorouracil;   Procedure: therapeutic conventional surgery;   Other: laboratory biomarker analysis
30 Recruiting Concurrent Chemoradiotherapy Containing Paclitaxel&Cisplatin With/Without Tarceva in Locally Advanced Esophageal Cancer
Condition: Esophageal Cancer
Interventions: Drug: Paclitaxel;   Drug: Cisplatin;   Drug: Tarceva;   Radiation: Radiotherapy
31 Recruiting Second-line Treatment With Icotinib in Esophageal Carcinoma Patients With EGFR Mutation
Conditions: Adenocarcinoma of the Gastroesophageal Junction;   Esophageal Carcinoma
Intervention: Drug: Icotinib
32 Recruiting A Study of Patient-reported Outcomes in Patients With Lung or Esophageal Cancer
Conditions: Lung Cancer;   Esophageal Cancer
Intervention:
33 Recruiting Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer Patients
Condition: Esophageal Cancer
Interventions: Drug: Endostar;   Radiation: Radiotherapy
34 Recruiting PReoperative Identification Of Response to Neoadjuvant Chemoradiotherapy for Esophageal Cancer
Condition: Esophageal Cancer
Intervention: Device: MRI and PET-CT
35 Unknown  Neoadjuvant Chemotherapy vs. Chemoradiation for Resectable Esophageal Cancer
Conditions: Esophageal Cancer;   Adenocarcinoma, Esophageal;   Squamous Cell Carcinoma, Esophageal;   Carcinoma, Gastroesophageal Junction
Interventions: Drug: carboplatin and paclitaxel;   Other: Carboplatin paclitaxel plus concurrent radiotherapy
36 Not yet recruiting Health-related Quality of Life of Patients With Esophageal Cancer After Surgery
Condition: Esophageal Cancer
Interventions: Procedure: MIE;   Procedure: Three-incision thoracotomy;   Procedure: Ivor-Lewis esophagectomy;   Procedure: Sweet esophagectomy
37 Recruiting Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer
Condition: Esophageal Cancer
Interventions: Drug: S-1 and Paclitaxel;   Drug: Paclitaxel and Cisplatin;   Drug: 5-FU and Cisplatin
38 Recruiting Radiotherapy & Olaparib in COmbination for Carcinoma of the Oesophagus
Condition: Carcinoma of the Oesophagus
Interventions: Drug: Olaparib;   Radiation: Radical external beam radiotherapy, 50Gy in 25 fractions
39 Unknown  Endoscopic Ultrasound Plus Submucosal Injection for Early Esophageal Cancer
Condition: Esophageal Cancer
Interventions: Device: submucosal injection needle ; EUS;   Device: ordinary endosonography(EUS)
40 Recruiting Phase II Trial of Thalidomide Combined With Concurrent Chemoradiotherapy in Esophageal Cancer
Condition: Esophageal Cancer
Interventions: Other: chemoradiotherapy;   Drug: thalidomide;   Other: without thalidomide

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years